These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 34922908)
1. Spontaneous recurrent seizures in an intra-amygdala kainate microinjection model of temporal lobe epilepsy are differentially sensitive to antiseizure drugs. West PJ; Thomson K; Billingsley P; Pruess T; Rueda C; Saunders GW; Smith MD; Metcalf CS; Wilcox KS Exp Neurol; 2022 Mar; 349():113954. PubMed ID: 34922908 [TBL] [Abstract][Full Text] [Related]
2. A face-to-face comparison of the intra-amygdala and intrahippocampal kainate mouse models of mesial temporal lobe epilepsy and their utility for testing novel therapies. Welzel L; Schidlitzki A; Twele F; Anjum M; Löscher W Epilepsia; 2020 Jan; 61(1):157-170. PubMed ID: 31828786 [TBL] [Abstract][Full Text] [Related]
3. Recurrent epileptiform discharges in the medial entorhinal cortex of kainate-treated rats are differentially sensitive to antiseizure drugs. West PJ; Saunders GW; Billingsley P; Smith MD; White HS; Metcalf CS; Wilcox KS Epilepsia; 2018 Nov; 59(11):2035-2048. PubMed ID: 30328622 [TBL] [Abstract][Full Text] [Related]
4. Inter-individual variation in the effect of antiepileptic drugs in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice. Klein S; Bankstahl M; Löscher W Neuropharmacology; 2015 Mar; 90():53-62. PubMed ID: 25460186 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of subchronic administration of antiseizure drugs in spontaneously seizing rats. Thomson KE; Metcalf CS; Newell TG; Huff J; Edwards SF; West PJ; Wilcox KS Epilepsia; 2020 Jun; 61(6):1301-1311. PubMed ID: 32420627 [TBL] [Abstract][Full Text] [Related]
6. Antiseizure drug efficacy and tolerability in established and novel drug discovery seizure models in outbred vs inbred mice. Koneval Z; Knox KM; Memon A; Zierath DK; White HS; Barker-Haliski M Epilepsia; 2020 Sep; 61(9):2022-2034. PubMed ID: 32757210 [TBL] [Abstract][Full Text] [Related]
7. Early polytherapy for benzodiazepine-refractory status epilepticus. Niquet J; Lumley L; Baldwin R; Rossetti F; Schultz M; de Araujo Furtado M; Suchomelova L; Naylor D; Franco-Estrada I; Wasterlain CG Epilepsy Behav; 2019 Dec; 101(Pt B):106367. PubMed ID: 31636007 [TBL] [Abstract][Full Text] [Related]
8. Single versus combinatorial therapies in status epilepticus: Novel data from preclinical models. Löscher W Epilepsy Behav; 2015 Aug; 49():20-5. PubMed ID: 25819944 [TBL] [Abstract][Full Text] [Related]
9. Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs. Löscher W Neurochem Res; 2017 Jul; 42(7):1873-1888. PubMed ID: 28290134 [TBL] [Abstract][Full Text] [Related]
10. Effect of carbamazepine on spontaneous recurrent seizures recorded from the dentate gyrus in rats with kainate-induced epilepsy. Grabenstatter HL; Dudek FE Epilepsia; 2019 Apr; 60(4):636-647. PubMed ID: 30815862 [TBL] [Abstract][Full Text] [Related]
11. Differential Effects of Antiepileptic Drugs on Focal Seizures in the Intrahippocampal Kainate Mouse Model of Mesial Temporal Lobe Epilepsy. Duveau V; Pouyatos B; Bressand K; Bouyssières C; Chabrol T; Roche Y; Depaulis A; Roucard C CNS Neurosci Ther; 2016 Jun; 22(6):497-506. PubMed ID: 26899987 [TBL] [Abstract][Full Text] [Related]
12. The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy. Twele F; Bankstahl M; Klein S; Römermann K; Löscher W Neuropharmacology; 2015 Aug; 95():234-42. PubMed ID: 25839899 [TBL] [Abstract][Full Text] [Related]
13. Knockout of P-glycoprotein does not alter antiepileptic drug efficacy in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice. Bankstahl M; Klein S; Römermann K; Löscher W Neuropharmacology; 2016 Oct; 109():183-195. PubMed ID: 27288003 [TBL] [Abstract][Full Text] [Related]
14. Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus. Brandt C; Volk HA; Löscher W Epilepsia; 2004 Dec; 45(12):1488-97. PubMed ID: 15571506 [TBL] [Abstract][Full Text] [Related]
16. High seizure frequency prior to antiepileptic treatment is a predictor of pharmacoresistant epilepsy in a rat model of temporal lobe epilepsy. Löscher W; Brandt C Epilepsia; 2010 Jan; 51(1):89-97. PubMed ID: 19563347 [TBL] [Abstract][Full Text] [Related]
17. Development of an antiepileptogenesis drug screening platform: Effects of everolimus and phenobarbital. Barker-Haliski M; Knox K; Zierath D; Koneval Z; Metcalf C; Wilcox KS; White HS Epilepsia; 2021 Jul; 62(7):1677-1688. PubMed ID: 34080183 [TBL] [Abstract][Full Text] [Related]
18. Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy. Riban V; Bouilleret V; Pham-Lê BT; Fritschy JM; Marescaux C; Depaulis A Neuroscience; 2002; 112(1):101-11. PubMed ID: 12044475 [TBL] [Abstract][Full Text] [Related]
19. The Search for New Screening Models of Pharmacoresistant Epilepsy: Is Induction of Acute Seizures in Epileptic Rodents a Suitable Approach? Löscher W Neurochem Res; 2017 Jul; 42(7):1926-1938. PubMed ID: 27502939 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the pentylenetetrazole seizure threshold test in epileptic mice as surrogate model for drug testing against pharmacoresistant seizures. Töllner K; Twele F; Löscher W Epilepsy Behav; 2016 Apr; 57(Pt A):95-104. PubMed ID: 26930359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]